Ghent University Academic Bibliography

Journal Article
A1
open access

No evidence for an association of HIV and antiviral treatment with changes in framingham cardiovascular risk score in the Ndlovu Cohort Study

Rita Verstraeten (UGent) , Alinda G. Vos‐Seda, Daniel Boateng, Karine Scheuermaier, Hugo Tempelman, Roos E. Barth, Walter Devillé, Roel A. Coutinho, Francois Venter, Diederick E. Grobbee, et al.

(2024) JOURNAL OF THE AMERICAN HEART ASSOCIATION. 13(2).

Add to list

Journal Article
A1
open access

Immune targeting of HIV-1 reservoir cells : a path to elimination strategies and cure

Marie Armani-Tourret, Benjamin Bone, Toong Seng Tan, Weiwei Sun, Maxime Bellefroid, Tine Struyve (UGent) , Michael Louella, Xu G. Yu and Mathias Lichterfeld

(2024) NATURE REVIEWS MICROBIOLOGY. 22. p.328-344

Add to list

Journal Article
A1
open access

Staging of immuno-virological dynamics during acute HIV infection in a Belgian prospective cohort study

Jozefien De Clercq (UGent) , Marie-Angélique De Scheerder (UGent) , Sophie Vanherrewege (UGent) , Els Caluwe (UGent) , Nathalie Moreels (UGent) , Danny Delooze, Annemieke Dhondt (UGent) , Marc Coppens (UGent) , Stefaan J. Vandecasteele, Sabine D. Allard, et al.

(2024) JOURNAL OF VIRUS ERADICATION. 10(3).

Add to list

A characterization of the HIV population with limited/exhausted treatment options : a multicenter Belgian study

Rakan Nasreddine, Gilles Darcis, Jean Cyr Yombi, Paul De Munter, Eric Florence, Jens Van Praet (UGent) , Rémy Demeester, Sabine D. Allard, Melanie Schroeder, Ange-Clarisse Dusabineza, et al.

(2024) ACTA CLINICA BELGICA. 79(3). p.153-159

Add to list

Journal Article
A1
open access

Systemic biological mechanisms underpin poor post-discharge growth among severely wasted children with HIV

Evans Oketch Mudibo (UGent) , Jasper Bogaert (UGent) , Caroline Tigoi, Moses M. Ngari, Benson O. Singa, Christina L. Lancioni, Abdoulaye Hama Diallo, Emmie Mbale, Ezekiel Mupere, John Mukisa, et al.

(2024) NATURE COMMUNICATIONS. 15(1).

Add to list

Journal Article
A1
open access

Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV : results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years of age

Franco Maggiolo, Giuliano Rizzardini, Jean‐Michel Molina, Federico Pulido, Stephane De Wit, Linos Vandekerckhove (UGent) , Juan Berenguer, Michelle L. D'Antoni, Christiana Blair, Susan K. Chuck, et al.

(2023) HIV MEDICINE. 24(1). p.27-36

Add to list

Journal Article
A1
open access

Nano drug-delivery systems for management of AIDS : liposomes, dendrimers, gold and silver nanoparticles

Fateme Davarani Asl, Marziyeh Mousazadeh, Shirinsadat Taji, Abbas Bahmani, Patricia Khashayar (UGent) , Mostafa Azimzadeh and Ebrahim Mostafavi

(2023) NANOMEDICINE. 18(3). p.279-302

Add to list

Journal Article
A1
open access

Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir

Marion Pardons (UGent) , Basiel Cole, Laurens Lambrechts (UGent) , Willem van Snippenberg (UGent) , Sofie Rutsaert (UGent) , Ytse Noppe (UGent) , Nele De Langhe (UGent) , Annemieke Dhondt (UGent) , Jerel Vega, Filmon Eyassu, et al.

(2023) NATURE COMMUNICATIONS. 14(1).

Add to list

Journal Article
A1
open access

A truncated HIV Tat demonstrates potent and specific latency reversal activity

Ellen Van Gulck, Marion Pardons (UGent) , Erik Nijs, Nick Verheyen, Koen Dockx, Christel van den Eynde, Emilie Battivelli, Jerel Vega, Eric Florence, Brigitte Autran, et al.

(2023) ANTIMICROBIAL AGENTS AND CHEMOTHERAPY. 67(11).

Add to list

Journal Article
A1
open access

Prevalence and evolution of transmitted human immunodeficiency virus drug resistance in Belgium between 2013 and 2019

Virginie Mortier (UGent) , Laurent Debaisieux, Geraldine Dessilly, Karolien Stoffels, Dolores Vaira, Ellen Vancutsem, Kristel Van Laethem, Fien Vanroye and Chris Verhofstede (UGent)

(2022) OPEN FORUM INFECTIOUS DISEASES. 9(7).

Academic Bibliography

No evidence for an association of HIV and antiviral treatment with changes in framingham cardiovascular risk score in the Ndlovu Cohort Study

Immune targeting of HIV-1 reservoir cells : a path to elimination strategies and cure

Staging of immuno-virological dynamics during acute HIV infection in a Belgian prospective cohort study

A characterization of the HIV population with limited/exhausted treatment options : a multicenter Belgian study

Systemic biological mechanisms underpin poor post-discharge growth among severely wasted children with HIV

Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV : results of a 96‐week, phase 3b, open‐label, switch trial in virologically suppressed people ≥65 years of age

Nano drug-delivery systems for management of AIDS : liposomes, dendrimers, gold and silver nanoparticles

Potent latency reversal by Tat RNA-containing nanoparticle enables multi-omic analysis of the HIV-1 reservoir

A truncated HIV Tat demonstrates potent and specific latency reversal activity

Prevalence and evolution of transmitted human immunodeficiency virus drug resistance in Belgium between 2013 and 2019

Contents

Support

Contact